CoChat

Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease

Open access
Lashley, T., Revesz, T., Plant, G., Bandopadhyay, R., Lees, A. J., Frangione, B., Wood, N. W., De Silva, R., Ghiso, J., Rostagno, A., Holton, J. L. · 2008 · Neuropathology and Applied Neurobiology

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 74 sources its claims cite is checked for support yet.

Abstract

Introduction: Two different disease‐specific mutations in the BRI2 gene, situated on chromosome 13, have been identified as giving rise to familial British dementia (FBD) and familial Danish dementia (FDD). Each mutation results in extension of the open reading frame generating the disease‐specific precursor proteins which are cleaved by furin‐like proteolysis releasing the amyloidogenic C‐terminal peptides ABri and ADan in FBD and FDD, respectively. Material and methods: To understand the mechanism of the formation of amyloid lesions in FBD, we studied the origin of the precursor proteins and furin in the human brain. We used control brains, cases of sporadic Alzheimer's disease (AD), variant AD with cotton wool plaques and FBD to study BRI2 mRNA expression using in situ hybridization. Furin and BRI2 protein expression was investigated using Western blotting and immunohistochemistry. Results: BRI2 mRNA and BRI2 protein are widely expressed primarily by neurones and glia and are deposited in the amyloid lesions in FBD. They were, however, not expressed by cerebrovascular components. Furin expression showed a similar pattern except that it was also present in cerebrovascular smooth muscle cells. Conclusions: These findings suggest that neurones and glia and are a major source of BRI2 protein and that in FBD, the mutated precursor protein may undergo furin cleavage within neurones to produce the amyloid peptide ABri. The failure to demonstrate BRI2 in blood vessels under the conditions tested suggests that vascular amyloid peptide production does not contribute significantly to cerebral amyloid angiopathy (CAA) in FBD and FDD, lending indirect support to the drainage hypothesis of CAA.

Overview

CoChat Summary

TL;DR

BRI2 mRNA and protein are widely expressed by neurones and glia throughout normal human brain, with furin showing a similar distribution except in cerebrovascular smooth muscle cells. In familial British dementia, BRI2 mRNA, BRI2 and furin are present in vascular and parenchymal amyloid lesions but not preamyloid lesions, suggesting local neuronal/glial production and processing rather than a major vascular origin of ABri.

Key findings

  • In normal human brain, BRI2 mRNA and BRI2 protein were widely expressed primarily by neurones and glia; vascular smooth muscle and endothelial cells showed no identifiable BRI2 mRNA or BRI2, while furin was present in cerebrovascular smooth muscle cells.
  • In FBD, parenchymal amyloid lesions contained BRI2 mRNA and BRI2 protein, and vascular amyloid deposits were associated with BRI2 mRNA and BRI2; preamyloid lesions were unstained. Furin was also found in FBD parenchymal and amyloid-laden vascular lesions.
  • In sporadic AD and variant AD with cotton wool plaques, BRI2 mRNA was found in amyloid plaques and amyloid-laden vessels, but no lesional deposition of BRI2 or furin was found in amyloid or preamyloid lesions.
  • Western and Northern analyses identified BRI2 mRNA at 2.0 kb, BRI2 protein at 39–41 kDa, and furin at 90 and 96 kDa.

Methods

  • Post-mortem flash-frozen brain tissue from four normal controls, one FBD case, four AD cases, and one variant AD case with cotton wool plaques; regions included frontal cortex, basal ganglia, hippocampus, cerebellum, and others depending on availability.
  • BRI2 mRNA expression was studied by in situ hybridization using three DIG-labelled oligonucleotide probes; BRI2 and furin protein expression was studied by Western blotting and immunohistochemistry, with double immunofluorescence using NeuN, GFAP, CD68, CR3/43 and Thioflavine-S.
  • Findings were compared descriptively across control, FBD, and AD cases; no quantitative statistical analysis is reported.

Limitations

  • The paper states that a small amount of BRI mRNA and BRI2 below the threshold of the methods used could be expressed by vascular components, as indicated by cell culture experiments; it also notes that Ab340 may recognize both full-length BRI2 and the N-terminal fragment generated by furin-like processing, so these fragments may contribute to positive immunohistochemical results.
  • Evident from the text: the sample is very small, especially one FBD case and one variant AD case, limiting generalizability.
  • Evident from the text: the biological function of BRI2 remains unknown, and the study relies on descriptive staining patterns without quantitative measures.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2990.2008.00935.x

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 44 Not checked · 75 Own results and interpretations

72 more claims

Create a free account to see all 119 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 23

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Stromgren E, 1981, Handbook of Clinical Neurology, 150

Cited by

See all 31

Metadata

Authors
Lashley, T., Revesz, T., Plant, G., Bandopadhyay, R., Lees, A. J., Frangione, B., Wood, N. W., De Silva, R., Ghiso, J., Rostagno, A., & Holton, J. L.
Affiliations
  • National Hospital for Neurology and Neurosurgery (GB)
  • New York University (US)
  • UCL Queen Square Institute of Neurology (GB)
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2008-09-29
Volume
34
Issue
5
Pages
492-505
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2076227489
Cited by
31
References
53
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 1
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • Neuropathology and Applied Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • American Heart Association
  • Alzheimer's Research Trust
  • National Institutes of Health
  • U.S. Public Health Service (AGO5891)
  • Medical Research Council (G0501560)
  • National Institute on Aging (P01AG010491, R37AG005891, R01AG010941)
  • National Institute of Neurological Disorders and Stroke (R01NS051715)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords
familial British dementia, familial Danish dementia, furin, amyloid precursor protein, amyloid plaques, neuronal expression, glial expression, cerebrovascular smooth muscle cells, cerebral amyloid angiopathy, sporadic Alzheimer's disease
MeSH terms
Adult, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Dementia, Female, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Male, Membrane Glycoproteins, Membrane Proteins, Middle Aged, Mutation, Neuroglia, Neurons, RNA, Messenger, Blotting, Northern, Blotting, Western, Polymerase Chain Reaction, In Situ Hybridization, Furin, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease. https://app.cochat.ai/papers/10.1111/j.1365-2990.2008.00935.x
The paper
Lashley, T., Revesz, T., Plant, G., Bandopadhyay, R., Lees, A. J., Frangione, B., Wood, N. W., De Silva, R., Ghiso, J., Rostagno, A., & Holton, J. L. (2008). Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.2008.00935.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.